Filter Results:
(395)
Show Results For
- All HBS Web
(395)
- News (48)
- Research (309)
- Multimedia (1)
- Faculty Publications (248)
Show Results For
- All HBS Web
(395)
- News (48)
- Research (309)
- Multimedia (1)
- Faculty Publications (248)
- January 12, 2017
- Article
What Cancer Researchers Can Learn from Direct-to-Consumer Companies
By: Richard G. Hamermesh and Kathryn E. Giusti
Hamermesh, Richard G., and Kathryn E. Giusti. "What Cancer Researchers Can Learn from Direct-to-Consumer Companies." Harvard Business Review (website) (January 12, 2017).
- September 2005
- Teaching Note
ProfitLogic (TN)
By: Richard G. Hamermesh and Michael J. Roberts
Teaching Note to (9-802-110), (9-806-702), and (9-806-705). View Details
- April 2004 (Revised May 2006)
- Background Note
Achieving Profitable Growth and Market Value
By: James L. Heskett and Richard G. Hamermesh
Provides an overview of how a new venture needs to change as it passes from the initial start-up to the growth phase. Explores how a venture's leadership, strategy, and execution need to evolve to deal with rapid growth. View Details
Heskett, James L., and Richard G. Hamermesh. "Achieving Profitable Growth and Market Value." Harvard Business School Background Note 804-157, April 2004. (Revised May 2006.)
- March 2003 (Revised June 2003)
- Teaching Note
Threshold Sports (TN)
By: Richard G. Hamermesh and Todd H Thedinga
Teaching Note for (9-803-134). View Details
Keywords: Sports Industry
- March 2003 (Revised January 2006)
- Case
Threshold Sports
By: Richard G. Hamermesh and Todd H Thedinga
Describes the sales, marketing, and operating issues facing Threshold Sports, a small cycling event management company that produces the Pro Cycling Tour. Examines the issues facing the company as it approaches breakeven and attempts to grow the business substantially.... View Details
Keywords: Growth Management; Bicycle Transportation; Service Delivery; Sports; Bicycle Industry; Service Industry
Hamermesh, Richard G., and Todd H Thedinga. "Threshold Sports." Harvard Business School Case 803-134, March 2003. (Revised January 2006.)
- June 1986
- Teaching Note
International Harvester (A), (B1), (B2), (B3), (B4), (C), and (D), Teaching Note
By: Richard G. Hamermesh and Evelyn T. Christiansen
- September 1983
- Supplement
Orthoteks USA (D)
Supplements the (A) case. View Details
Badaracco, Joseph L., Jr., and Richard G. Hamermesh. "Orthoteks USA (D)." Harvard Business School Supplement 384-062, September 1983.
- September 1983 (Revised May 1999)
- Supplement
Orthoteks USA (B3)
Supplements the (A) case. View Details
Badaracco, Joseph L., Jr., and Richard G. Hamermesh. "Orthoteks USA (B3)." Harvard Business School Supplement 384-060, September 1983. (Revised May 1999.)
- September 1983 (Revised July 1991)
- Case
Orthoteks USA (A)
A series on implementing strategy as the head of the U.S. subsidiary of a successful Swiss medical products firm. Traces the actions of the CEO over a four year period and highlights his negotiations with the Swiss parent and the way functional components of the... View Details
Keywords: Business Subsidiaries; Trade; Health Care and Treatment; Leadership Style; Agreements and Arrangements; Strategy; Health Industry; Switzerland; United States
Badaracco, Joseph L., Jr., and Richard G. Hamermesh. "Orthoteks USA (A)." Harvard Business School Case 384-057, September 1983. (Revised July 1991.)
- September 1983 (Revised July 1986)
- Supplement
Orthoteks USA (C)
Supplements the (A) case. View Details
Badaracco, Joseph L., Jr., and Richard G. Hamermesh. "Orthoteks USA (C)." Harvard Business School Supplement 384-061, September 1983. (Revised July 1986.)
- September 1983 (Revised September 1985)
- Supplement
Orthoteks USA (B2)
Supplements the (A) case. View Details
Badaracco, Joseph L., Jr., and Richard G. Hamermesh. "Orthoteks USA (B2)." Harvard Business School Supplement 384-059, September 1983. (Revised September 1985.)
- June 11, 2021
- Article
Addressing Demographic Disparities in Clinical Trials
By: Kathy Giusti, Richard G. Hamermesh and Mark Krasnow
Disparities in health care are not just limited to the delivery of care. They also exist in the way that clinical trials are structured. Women, people of color, and the elderly often are not adequately represented. This article offers three strategies for addressing... View Details
Giusti, Kathy, Richard G. Hamermesh, and Mark Krasnow. "Addressing Demographic Disparities in Clinical Trials." Harvard Business Review Digital Articles (June 11, 2021).
- March 2011 (Revised March 2011)
- Case
Horizon Blue Cross Blue Shield of New Jersey - Managing in the Shadow of Health Care Reform
Per the Patient Protection and Affordable Care Act (PPACA), which President Obama signed in 2010, states would be required to create state-wide health insurance marketplaces - the Health Benefit Exchanges (HBEs) - in which individuals and small employers could choose... View Details
Keywords: Insurance; Health Care and Treatment; Governing Rules, Regulations, and Reforms; Emerging Markets; Risk and Uncertainty; Health Industry; Insurance Industry; New Jersey
Oberholzer-Gee, Felix, Raffaella Sadun, and Richard G. Hamermesh. "Horizon Blue Cross Blue Shield of New Jersey - Managing in the Shadow of Health Care Reform." Harvard Business School Case 711-403, March 2011. (Revised March 2011.)
- October 2005 (Revised September 2006)
- Case
DentalCorp
By: Richard G. Hamermesh and Ricardo Reisen de Pinho
DentalCorp is the fifth largest provider of dental insurance in Brazil and has tripled its sales in the past two years. Whether to expand to Chile or to continue expansion in Brazil is the major strategic choice facing the company at the end of 2004. View Details
Keywords: International Finance; Expansion; Entrepreneurship; Health Care and Treatment; Global Strategy; Insurance Industry; Health Industry; Brazil; Chile
Hamermesh, Richard G., and Ricardo Reisen de Pinho. "DentalCorp." Harvard Business School Case 806-023, October 2005. (Revised September 2006.)
- January 2005 (Revised March 2006)
- Case
Molecular Insight Pharmaceuticals, Inc.
By: Richard G. Hamermesh and Edwin W. Parkinson III
Molecular Insight has developed a novel biopharmaceutical to detect heart attacks. The company's unique approach to intellectual property protection uses the Hatch Waxman Act and the Orphan Drug Act. The company is struggling to raise $7 million in Series B financing.... View Details
Keywords: Intellectual Property; Health Care and Treatment; Pharmaceutical Industry; Health Industry
Hamermesh, Richard G., and Edwin W. Parkinson III. "Molecular Insight Pharmaceuticals, Inc." Harvard Business School Case 805-067, January 2005. (Revised March 2006.)
- 01 Jun 1996
- News
New Releases
Engines of Innovation edited by Richard S. Rosenbloom and William J. Spencer (HBS Press) In past decades, industrial laboratories such as AT&T's Bell Labs and the Xerox Palo Alto Research Center were... View Details
- November 2010 (Revised January 2011)
- Case
Computerized Provider Order Entry at Emory Healthcare
By: Richard G. Hamermesh, F. Warren McFarlan, Mark Keil, Andrew Katz, Michael Morgan and David LaBorde
The Computerized Provider Order Entry at Emory Healthcare case presents one hospital system's efforts to implement computerized provider order entry (CPOE) across all of its hospitals and the challenges they faced in doing so. Issues such as standardization of care,... View Details
Keywords: Health Care and Treatment; Information Management; Management Systems; Standards; Service Delivery; Business Processes; Organizational Change and Adaptation; Projects; Information Technology; Applications and Software; Health Industry
Hamermesh, Richard G., F. Warren McFarlan, Mark Keil, Andrew Katz, Michael Morgan, and David LaBorde. "Computerized Provider Order Entry at Emory Healthcare." Harvard Business School Case 311-061, November 2010. (Revised January 2011.)
- April 2008
- Supplement
ProfitLogic (CW)
By: Lynda M. Applegate, Richard G. Hamermesh and Michael J. Roberts
This interactive spreadsheet accompanies the ProfitLogic case (#802-110) to enable analysis of the cash flow implications of three business models that the company is considering. Students are able to change key assumptions and see the impact on cash flow. View Details
- March 2010
- Supplement
Whose Money Is It Anyway? (C)
By: V.G. Narayanan, Richard G. Hamermesh and Rachel Gordon
The case describes how the Brigham and Women's Physicians Organization and its corporate parent resolved the issue of how the disputed funds would be distributed and used. View Details
Keywords: Corporate Governance; Business Subsidiaries; Organizational Design; Conflict and Resolution; Resource Allocation; Health Industry
Narayanan, V.G., Richard G. Hamermesh, and Rachel Gordon. "Whose Money Is It Anyway? (C)." Harvard Business School Supplement 810-031, March 2010.
- March 2010
- Supplement
Whose Money Is It Anyway? (B)
By: V.G. Narayanan, Richard G. Hamermesh and Rachel Gordon
The case describes the various reactions of doctors and administrators to the solutions they developed. View Details
Narayanan, V.G., Richard G. Hamermesh, and Rachel Gordon. "Whose Money Is It Anyway? (B)." Harvard Business School Supplement 810-013, March 2010.